Search company, investor...


Founded Year



Series B - II | Alive

Total Raised


Last Raised

$2.04M | 8 yrs ago

About Medipacs

Medipacs develops a non-mechanical infusion pump using a expandable polymer. TheMedipacs pump is designed to be wearable, programmable and disposable to allow for greater accuracy, patient comfort and convenience at a lower cost. The Medipacs novel polymer technology enables drug infusion pumps that are wearable, programmable and disposable to allow for greater accuracy, patient comfort and convenience at a lower cost.

Headquarters Location

13220 Evening Creek Drive Suite 111

San Diego, California, 92128,

United States


Missing: Medipacs's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Medipacs's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Medipacs Patents

Medipacs has filed 1 patent.

The 3 most popular patent topics include:

  • Dosage forms
  • Drug delivery devices
  • Medical equipment
patents chart

Application Date

Grant Date


Related Topics




Dosage forms, Polymers, Drug delivery devices, Organic polymers, Amines


Application Date


Grant Date



Related Topics

Dosage forms, Polymers, Drug delivery devices, Organic polymers, Amines



Medipacs Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Medipacs Rank

Medipacs Frequently Asked Questions (FAQ)

  • When was Medipacs founded?

    Medipacs was founded in 2004.

  • Where is Medipacs's headquarters?

    Medipacs's headquarters is located at 13220 Evening Creek Drive, San Diego.

  • What is Medipacs's latest funding round?

    Medipacs's latest funding round is Series B - II.

  • How much did Medipacs raise?

    Medipacs raised a total of $5.49M.

  • Who are the investors of Medipacs?

    Investors of Medipacs include Desert Angels, Solstice Capital, RoundTable Healthcare Partners, Mesa Verde Venture Partners and Arizona Center for Innovation.

  • Who are Medipacs's competitors?

    Competitors of Medipacs include Erydel, Sol-Gel, Cellnovo, Ekos, Orthocon and 10 more.

Compare Medipacs to Competitors


Making the pain of injections go away in children, adults and seniors, is Israel's Sindolor. Based in Ramat Gan, under the TASE-traded mother company D Medical Industries, Sindolor is about to release its EZject drug delivery platform.


EryDel develops a red-blood-cell-based drug delivery device for the treatment of rare neurodegenerative diseases. Its proprietary technology relies upon the encapsulation of drugs into red cells taken from the patient's own blood, which are then re-infused into the patient.

Cambridge Eyenovations

Cambridge Eyenovations is developing drug-eluting contact lenses that can dispense medicine automatically for glaucoma patients so that people don't need to put in eyedrops at all, and can go a month without changing contact lenses.


Nanomi develops membrane emulsification process technology and equipment for:nn * monodisperse emulsionsn * monodisperse double emulsionsn * monodisperse microspheres (e.g. drug delivery systems)n * monodisperse microbubblesnnHeart of the company's technology is a emulsification membrane, fabricated with microscopic precision by proven photolithographic processes from the semiconductor industry. Nanomi follow a partnering strategy where the combination of the company's technology and their application formulation will enable users to provide their customers with new high value-added products.n

R4 Vascular Logo
R4 Vascular

Vascular is driving innovation in vascular access medical technology. The company's passion is uncomplicating venous access, chemotherapy, and drug delivery. The company's product designs offer rapid exchange, Biomimetic coating, power injection ability, and associated improvements that help the company's catheters remain patent and effective. Learn more about how the company's products can improve patient care through reduced complications, while delivering lower overall costs for access and drug delivery.


Medlogics is an early stage medical device company developing a broad platform technology for drug delivery. The initial focus is product development of polymer-free stent drug delivery.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.